These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 13807725)

  • 1. [On the vasodilating and fibrinolytic action of nicotinic acid in the therapy of pregnancy toxicoses].
    CARLI R
    Quad Clin Ostet Ginecol; 1960 Apr; 15():237-46. PubMed ID: 13807725
    [No Abstract]   [Full Text] [Related]  

  • 2. [CLINICAL EVALUATION OF THE USE OF A DRUG WITH FIBRINOLYTIC ACTION IN THE THERAPY OF GESTOSIS IN THE THIRD TRIMESTER].
    MARZETTI L; BENAGIANO G
    Clin Ostet Ginecol; 1964 Aug; 66():429-43. PubMed ID: 14228276
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of some vasoactive drugs on fibrinolytic activity.
    WEINER M; DE CRINIS K; REDISCH W; STEELE JM
    Circulation; 1959 Jun; 19(6):845-8. PubMed ID: 13663173
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the applicability of cosaldon in the treatment of cerebral sclerotic parkinsonism].
    EHLERS G
    Munch Med Wochenschr; 1959 Aug; 101():1355-7. PubMed ID: 13819571
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of late pregnancy toxicosis with vasodilating and blood circulation stimulating drugs].
    WAGNER H
    Zentralbl Gynakol; 1955; 77(40):1577-87. PubMed ID: 13300831
    [No Abstract]   [Full Text] [Related]  

  • 6. [POSSIBILITIES AND ADVANTAGES OF FIBRINOLYTIC DRUGS IN THERAPY OF KIDNEY DISEASE IN PREGNANCY].
    MARZETTI L
    Quad Clin Ostet Ginecol; 1964 Jul; 19():346-52. PubMed ID: 14242595
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of the results obtained with nicotinic acid in the therapy of pregnancy toxemia].
    FERRARI B
    Clin Ostet Ginecol; 1963 Apr; 65():165-72. PubMed ID: 13944830
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of pregnancy toxicosis including hyperemesis gravidarum with Vi-Nicotyl Wander].
    WIDMER W
    Schweiz Med Wochenschr; 1948 Jan; 78(1):20. PubMed ID: 18868517
    [No Abstract]   [Full Text] [Related]  

  • 9. [APROPOS OF THROMBOLYTIC THERAPY].
    DONNER L
    Cas Lek Cesk; 1964 Jan; 103():102-7. PubMed ID: 14129510
    [No Abstract]   [Full Text] [Related]  

  • 10. [Eruptions following therapeutic use of nicotinic acid for vasodilation].
    THIERS H; RACOUCHOT J; THIVOLET
    Lyon Med; 1952 Jul; 187(27):11-2. PubMed ID: 12991878
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinolytic action of nicotinic acid].
    MARRAZZA P; LUCA S
    Acta Vitaminol; 1960 Oct; 14():207-9. PubMed ID: 13767111
    [No Abstract]   [Full Text] [Related]  

  • 12. [Stimulation of vascular reactions in normal pregnancy and in toxicosis].
    ODELLO V
    Pathologica; 1959; 51():569-72. PubMed ID: 14428284
    [No Abstract]   [Full Text] [Related]  

  • 13. [INFLUENCE OF A NICOTINIC ACID DERIVATIVE ON FIBRINOLYTIC PROCESSES].
    PERICOLI F; NUZZI R
    Policlinico Prat; 1963 Nov; 70():1589-95. PubMed ID: 14115994
    [No Abstract]   [Full Text] [Related]  

  • 14. EFFECT OF NICOTINIC ACID ON FIBRINOLYTIC ACTIVITY OF THE BLOOD IN ATHEROSCLEROSIS.
    SHERSHEVSKII MG
    Fed Proc Transl Suppl; 1963; 22():1154-6. PubMed ID: 14079323
    [No Abstract]   [Full Text] [Related]  

  • 15. Inositol niacinate as a peripheral vasodilator.
    LUMISH SH; BLYN C; NODINE JH
    Curr Ther Res Clin Exp; 1962 May; 4():243-8. PubMed ID: 14467334
    [No Abstract]   [Full Text] [Related]  

  • 16. [Some aspects of nicotinic acid metabolism during the treatment of pregnant subjects with early toxicoses].
    GORVAT VF
    Akush Ginekol (Mosk); 1961; 37():57-61. PubMed ID: 13707334
    [No Abstract]   [Full Text] [Related]  

  • 17. [Trials with a vasodilative salve to prevent cold injuries].
    THOREN O; FOLKOW B
    Tidskr Mil Halsov; 1959; 84():85-97. PubMed ID: 13838191
    [No Abstract]   [Full Text] [Related]  

  • 18. Observations on the use of nicotinic acid to induce in vivo fibrinolytic activity.
    WILSON WL; FOSTIROPOULOS G
    Am J Med Sci; 1959 Nov; 238():591-7. PubMed ID: 13845147
    [No Abstract]   [Full Text] [Related]  

  • 19. Speripheral vascular disease in general practice. Some experiences with meso-inositol-hexanicotinate.
    HAMILTON RR
    Practitioner; 1960 Mar; 184():367-9. PubMed ID: 14399278
    [No Abstract]   [Full Text] [Related]  

  • 20. THE INFLUENCE OF AN INCREASED PLASMA FIBRINOLYTIC ACTIVITY ON THE PROTEIN PATTERN.
    BOGDANIKOWA B; BIELAWIEC M
    Sangre (Barc); 1964; 61():37-40. PubMed ID: 14214882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.